Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. (Q48954446)

17 February 2018

title

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. (English)

1 reference

17 February 2018

author

Hong-Nerng Ho

5

1 reference

17 February 2018

Chin-Der Chen

1 reference

ORCID Public Data File 2021

Jehn-Hsiahn Yang

1 reference

ORCID Public Data File 2021

author name string

Chen CD

1

1 reference

17 February 2018

Wu MY

2

1 reference

17 February 2018

Yang JH

3

1 reference

17 February 2018

Chen SU

4

1 reference

17 February 2018

Yang YS

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

17 February 2018

published in

Fertility and Sterility

1 reference

17 February 2018

volume

68

1 reference

17 February 2018

issue

2

1 reference

17 February 2018

page(s)

287-291

1 reference

17 February 2018

Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Severe ovarian hyperstimulation despite prophylactic albumin at the time of oocyte retrieval for in vitro fertilization and embryo transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

The evaluation of therapies: historical control studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Effect of the number and depth of embryos transferred and unilateral or bilateral transfer in tubal embryo transfer (TET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981517-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(97)81517-8

1 reference

17 February 2018

1 reference

17 February 2018